MTP Supports SVA – Riding with Purpose for the 2023 MACA Cancer 200 Ride for Research
Malcolm Thompson Pumps (MTP) recently sponsored Support Vehicles Australia (SVA) for their participation in the MACA Cancer 200 Ride for Research – a 200km journey dedicated to raising vital funds for cancer research through the Harry Perkins Institute of Medical Research.
The SVA team, fuelled by their passion for this wonderful cause, and their dedication to this long-distance ride, achieved a remarkable outcome – exceeding their initial fundraising target and raising a fantastic $47,000 for the groundbreaking work done by the Harry Perkins Institute of Medical Research.
Since its inception in 1998, the Harry Perkins Institute of Medical Research has made significant discoveries into the diseases that plague our families, in particular heart disease, diabetes and cancer. With over 200 researchers, scientists and doctors housed in two state-of-the-art research facilities, the Perkins creates a culture of innovation and collaboration. Teams dedicated to finding answers to defeat cancers are funded from the MACA Cancer 200 each year.
SVA riding in this event and raising awareness and funds for goes a long way towards helping the Institute do their incredibly valuable work and making new, and helpful discoveries.
The Significance of Cancer Research
The study of cancers is essential to help continue to find new and better ways to prevent, diagnose, and treat. Thanks to the investigation being done in this area, significant progress has been made in recent years. For example, the five-year survival rate for all cancers has increased from 49% in 1990, to 69% in 2019.
Making a Meaningful Impact
Supporting the MACA Cancer 200 Ride for Research means supporting the work of Professor Jonas Nilsson. Professor Nilsson joined to the Harry Perkins Institute from Gothenburg, Sweden in 2020 to take up the inaugural position of Chair of Melanoma Discovery. His aim is to improve the survival for melanoma patients in WA.
Melanoma research is a strong area of focus for the Perkins Institute and the MACA Ride makes a truly meaningful impact, with funds Professor Nilsson’s Australian-first melanoma research.
Support of the MACA Cancer 200 ride has the potential to save many lives – while other labs are working on a ‘magic bullet’ breakthrough for melanoma patients, Professor Nilsson explained that this cell therapy treatment has an immediate benefit, with the potential to save many lives.
Professor Nilsson’s work and lab is one of the many important projects that MTP, SVA and the fundraising efforts of the MACA Cancer 200 sponsorship. Through our backing of this journey, we are helping to continue this incredible work and that of other cancer researchers benefiting from the generosity and commitment of those who support it.
